diethylnitrosamine has been researched along with sirolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brilliant, KE; Cerretti, B; Claro, P; Clift, D; Gruppuso, PA; Hixson, DC; Mills, DR; Patel, A; Sanders, JA | 1 |
Aghajan, M; Hall, MN; Karin, M; Lee, JH; Nakagawa, H; Park, EJ; Seki, E; Shalapour, S; Taniguchi, K; Umemura, A; Valasek, MA | 1 |
2 other study(ies) available for diethylnitrosamine and sirolimus
Article | Year |
---|---|
The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Proliferation; Cell Shape; Cell Transformation, Neoplastic; Choline Deficiency; Diethylnitrosamine; Dual-Specificity Phosphatases; Ethionine; Fluorenes; Gene Expression Profiling; Hepatectomy; Hepatocytes; Liver Neoplasms, Experimental; Male; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinase Phosphatases; Multiprotein Complexes; Precancerous Conditions; Proteins; Rats; Sirolimus; TOR Serine-Threonine Kinases | 2012 |
Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Diet, High-Fat; Diethylnitrosamine; DNA Damage; Fatty Liver; Glucose Tolerance Test; Hepatocytes; Humans; Inflammation; Interleukin-6; Liver; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mitosis; Multiprotein Complexes; Reactive Oxygen Species; Regulatory-Associated Protein of mTOR; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases | 2014 |